C8H13NO
139.19 g/mol
Pharmaceutical IntermediateWarning
Spiro[1-azabicyclo[2.2.2]octane-3,2'-oxirane]
CAS41353-91-7EC111-446-1
Category
Pharmaceutical Intermediate
Compound Class
Heterocycle
Primary Use
Pharmaceutical Intermediate
This compound is a spirocyclic oxirane derivative of quinuclidine, characterized by a rigid tricyclic structure containing both an amine and an ether functional group. It is primarily used as a pharmaceutical intermediate in the synthesis of more complex molecules.
pharmaceutical intermediatebuilding block for organic synthesis
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 41353-91-7
Related Compounds
StrongSame Parent
Spiro[1-azabicyclo[2.2.2]octane-3,2'-oxirane] hydrochloride
CAS64168-68-9
pharmaceutical intermediate
ReferenceSame Category
P-aminosalicylic acid methyl ester
CAS4136-97-4
pharmaceutical intermediate
ReferenceSame Category
Nipecotamide
CAS4138-26-5
pharmaceutical intermediate
ReferenceSame Category
2-Bromo-5-fluoropyridine
CAS41404-58-4
pharmaceutical intermediate
ReferenceSame Category
N-{2-[4-(AMINOSULFONYL)PHENYL]ETHYL}ACETAMIDE
CAS41472-49-5
pharmaceutical intermediate
Safety Reference
Warning
H315Causes skin irritation
H317May cause an allergic skin reaction
H319Causes serious eye irritation
H410Very toxic to aquatic life with long lasting effects
Identifiers
IUPAC Name
spiro[1-azabicyclo[2.2.2]octane-3,2'-oxirane]
InChIKey
TYCHQBRUARUTCL-UHFFFAOYSA-N
SMILES
C1CN2CCC1C3(C2)CO3
Synonyms (7)
—